Skip to content
10-Q

Quarterly Report

RETINALGENIX TECHNOLOGIES INC. RTGN

0001493152-24-020564

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 17.86M sh
Total Liabilities Q1 2024 · Mar 31, 2024 $1.57M
Total Liabilities Q1 2024 · Dec 31, 2023 $1.41M
Current Assets Q1 2024 · Mar 31, 2024 $50.39K
Current Assets Q1 2024 · Dec 31, 2023 $0
Total Assets Q1 2024 · Mar 31, 2024 $50.52K
Total Assets Q1 2024 · Dec 31, 2023 $156
Net Income Q1 2024 · Dec 31, 2023 −$2.09M
Shares Diluted Q1 2024 · Mar 31, 2023 17.27M sh
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.03